CMPX
CMPX
US20454B1044
Compass Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- 850.000
--
Cost of Revenue -- --
--
Gross Profit -- --
--
72.839.000 57.475.000
26.7%
Operating Income -72.839.000 -56.625.000
28.6%
Pretax Income -66.489.000 -49.375.000
34.7%
Net Income Common Stockholders -66.489.000 -49.375.000
34.7%
-- --
--
-- --
--
ende